Xiaofan Zhu, MD
Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC · Chinese Academy of Medical Sciences · Department of Pediatrics, CAMS&PUMC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xiaofan Zhu, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:45 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07751588 · Plasma ctDNA Monitoring in Pediatric Acute LeukemiaInstitute of Hematology & Blood Diseases Hospital, China · not yet recruiting · Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia · principal investigator
- Ph3NCT07152041 · Newly-diagnosed Pediatric Ph-positive B-ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), Childhood Leukemia, Acute Lymphoblastic · principal investigator
- Ph2/Ph3NCT06882057 · Newly-diagnosed Low Risk Pediatric B-cell ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL) · principal investigator
- Ph2/Ph3NCT06855810 · Newly-diagnosed Pediatric T-cell ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma · principal investigator
- Ph2/Ph3NCT06764238 · Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL) · principal investigator
- Ph1NCT05495035 · Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALLInstitute of Hematology & Blood Diseases Hospital, China · recruiting · Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed Leukemia · principal investigator
- Ph4NCT02953730 · The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and AdolescentsChinese Academy of Medical Sciences · completed · Acute Lymphoid Leukemia · principal investigator
- Ph4NCT02218437 · Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells(Umbilical Cord Derived)Chinese Academy of Medical Sciences · unknown · Complications of Organ Transplant Stem Cells Umbilical Cord · principal investigator
- Ph4NCT01990807 · Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic LeukemiaChinese Academy of Medical Sciences · unknown · Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Ph^1^, Absent, B-cell Childhood Acute Lymphoblastic Leukemia · principal investigator
- Ph4NCT01191541 · Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)Xiaofan Zhu · completed · Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.